Susquehanna International Group, LLP Medicinova Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Medicinova Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 56,999 shares of MNOV stock, worth $104,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,999

Previous 11,199 408.97%

Holding current value

$104,308

Previous $16,000 643.75%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.13 - $2.1 $51,753 - $96,180	45,800 Added 408.97%	56,999 $119,000
Q2 2024 Aug 15, 2024	BUY	$1.28 - $1.57 $14,334 - $17,582	11,199 New	11,199 $16,000
Q4 2023 Feb 14, 2024	BUY	$1.38 - $2.06 $11,883 - $17,738	8,611 Added 65.56%	21,745 $32,000
Q3 2023 Nov 14, 2023	BUY	$2.01 - $2.6 $26,399 - $34,148	13,134 New	13,134 $27,000
Q1 2023 May 16, 2023	SELL	$1.95 - $2.54 $62,743 - $81,727	-32,176 Reduced 50.0%	32,180 $69,000
Q4 2022 Feb 14, 2023	SELL	$1.97 - $2.66 $96,051 - $129,693	-48,757 Reduced 43.1%	64,356 $131,000
Q3 2022 Nov 14, 2022	SELL	$2.1 - $2.6 $82,437 - $102,065	-39,256 Reduced 25.76%	113,113 $245,000
Q2 2022 Aug 15, 2022	SELL	$2.31 - $3.14 $266,051 - $361,646	-115,174 Reduced 43.05%	152,369 $385,000
Q1 2022 May 16, 2022	SELL	$2.19 - $2.81 $19,129 - $24,545	-8,735 Reduced 3.16%	267,543 $714,000
Q4 2021 Feb 14, 2022	BUY	$2.61 - $4.42 $247,785 - $419,621	94,937 Added 52.35%	276,278 $740,000
Q3 2021 Nov 15, 2021	BUY	$3.4 - $4.24 $285,436 - $355,956	83,952 Added 86.2%	181,341 $687,000
Q2 2021 Aug 11, 2021	BUY	$3.76 - $5.14 $290,174 - $396,674	77,174 Added 381.77%	97,389 $414,000
Q1 2021 May 17, 2021	BUY	$4.81 - $8.74 $10,028 - $18,222	2,085 Added 11.5%	20,215 $102,000
Q4 2020 Feb 16, 2021	SELL	$5.03 - $6.31 $3,878 - $4,865	-771 Reduced 4.08%	18,130 $95,000
Q3 2020 Nov 16, 2020	BUY	$4.67 - $11.0 $88,267 - $207,911	18,901 New	18,901 $99,000
Q2 2020 Aug 14, 2020	SELL	$3.06 - $7.06 $40,563 - $93,587	-13,256 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.9 - $6.97 $38,442 - $92,394	13,256 New	13,256 $49,000
Q4 2019 Feb 14, 2020	SELL	$6.48 - $8.76 $122,264 - $165,283	-18,868 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.7 - $10.42 $12,127 - $16,411	1,575 Added 9.11%	18,868 $150,000
Q2 2019 Aug 16, 2019	BUY	$8.29 - $13.22 $20,393 - $32,521	2,460 Added 16.58%	17,293 $167,000
Q2 2019 Aug 14, 2019	BUY	$8.29 - $13.22 $122,965 - $196,092	14,833 New	14,833 $143,000
Q1 2019 May 15, 2019	SELL	$6.82 - $10.27 $154,684 - $232,933	-22,681 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.65 - $12.83 $173,509 - $290,997	22,681 New	22,681 $185,000

Others Institutions Holding MNOV

# of Institutions

Shares Held

4.83M

Call Options Held

9.4K

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $89.8M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Medicinova Inc Transaction History